Community Pharmacy Roadmap Program Development Template
|
|
- Francine Clarke
- 8 years ago
- Views:
Transcription
1 Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: Pharmacist Only Medicine Notifiable (POMN) B- Pharmacy medicines and health products services and programs 1. Program/Service Description a) Background Medicines and poisons are classified into schedules to allow restrictions to be placed on their supply to the public, in the interests of public health and safety. The Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) 1, or Poisons Standard, is the legislative instrument that lists medicines and poisons according to their schedule classification. The implementation of the SUSMP, as it affects access to and supply of medicines and poisons, is given legal effect through the relevant State and Territory drugs, poisons and controlled substances legislation. Poisons for therapeutic use (medicines) are mostly included in Schedules 2, 3, 4 & 8, with progression through these schedules signifying increasingly restrictive regulatory controls, whilst medicines that are exempt from scheduling are available through the grocery sector. Schedule 2 (Pharmacy Medicine) Pharmaceuticals that can only be supplied through a pharmacy. This category is for substances for which the safe use may require advice from a pharmacist, and should therefore only be available from a pharmacy. Schedule 3 (Pharmacist Only Medicine) Pharmaceuticals which must be supplied by a pharmacist in a pharmacy. This category is for substances for which the safe use requires professional advice, but which should be available to the public without a prescription. Schedule 4 (Prescription Only Medicine) Medicines that can only be obtained with a prescription. This category is for substances for which the use or supply should be by or on the order of persons permitted by State or Territory legislation to prescribe (i.e. a doctor) and should only be available from a pharmacist on prescription. Schedule 8 (Controlled Drug) Drugs of addiction. This category is for substances that should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence. Discussions regarding the introduction of a sub-schedule to the current Schedule 3 category, namely a Pharmacist Only Medicine Notifiable (POMN) have been held with government in recent years. The rationale for such an approach is set out below. The proposal would otherwise retain the current scheduling arrangements for non-prescription medicines. The sale of medicines in the POMN category would be recorded by the pharmacist in order to monitor usage. POMN medicines may include those with a potential for misuse and/or abuse, as well as other medicines where it is considered clinically appropriate. This would also provide a platform for the potential down-scheduling of medicines from the Prescription Only (S4) category. Variations of POMN currently in practice include: Project STOP, which involves the real-time recording and monitoring of the sales of 1 1
2 pseudoephedrine products, to minimise criminal diversion. Asthma Card 2, which is a hard-copy record in WA and NSW/ACT for the over-thecounter sales of asthma relievers, which provides pharmacists a tool to assist patients selfmanage their condition Further to the above, various health bodies have called for a POMN-type status or a similar real-time monitoring/notification scheme to apply to combination analgesics containing codeine (CACC), such as codeine-ibuprofen and codeine-paracetamol products. It is wellestablished that, while most people use these medicines appropriately, a small minority abuse them due to an addiction to codeine, which is often initiated by excessive use of these medicines to address chronic pain. Such misuse has resulted in serious health consequences. 3 Concerns over this matter led the then National Drugs and Poisons Schedule Committee (NDPSC) to change the scheduling restrictions for CACC, limiting the strength and quantity that can be supplied over the counter (OTC) and stipulating pharmacist intervention through scheduling as a Pharmacist Only Medicine (POM) (S3). These changes were applied from May 1 st, However, it is noteworthy that prominent health bodies continue to call for real-time monitoring of these medicines, contending that the recent scheduling changes do not adequately address the issue of misuse. It is interesting to note developments outlined above against the back-drop of the recommendations from the Galbally Review of Drugs, Poisons and Controlled Substances Legislation 4, which identified that mandatory recording of the retail supply of S3 medicines has limited use because there is no real time monitoring (pg 119 of part B). The Galbally Review advised that the mandatory recording of supply of S3 medicines should be considered on a case by case basis rather than as a broad application. b) Brief Description A POMN medicine would be recorded in a database, with national integrated access by the community pharmacy network on a real-time basis where this is considered appropriate. This would provide a platform for pharmacists to observe and monitor medicine usage to assist them in providing advice to their patients. It would also allow for data to be gathered by relevant health authorities. This technology would be applied to non-prescription medicines in cases: where there is a risk of misuse/abuse, such as codeine-containing analgesics or pseudoephedrine; and where such arrangements may improve the safe and appropriate use of the identified medicines, such as asthma relievers. A POMN schedule will include the following key features: real-time monitoring, where this is considered appropriate, of those medicines by community pharmacists across all pharmacies; mandatory recording requirements; consistency across all jurisdictions; and the gathering of de-identified data for provision to relevant health and other authorities where appropriate. This then provides the opportunity for interventions such as: pharmacist advice, support or referral where the requested use of the medicine is contrary to specific drug protocols or not consistent with Quality Use of Medicine (QUM) principles; and identification of patterns or trends by health agencies to inform, develop and improve health policy See, for example, MY Frei, S Nielsen, M Dobbin & CL Tobin; Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases; MJA 2010; 193 (5): Review of Drugs, Poisons & Controlled Substances Legislation, A Council of Australian Governments Review, January
3 c) Alignment with Government Policy d) Expected Outcomes for Government and Community Pharmacy The objectives of a POMN category are closely aligned with the key objectives of Australia s continuing health reform agenda. Reports from the Preventative Health Taskforce, National Primary Healthcare Strategy and National Health and Hospitals Reform Commission emphasise the themes of improved self-care and health literacy, prevention, and strengthening primary care through better use of primary health care providers, including pharmacists. From a government perspective, the establishment of a POMN system would: facilitate the collection and analysis of critical health care and supply data through an IT system, thus providing evidence to inform future policy; facilitate earlier health professional engagement with those misusing medicines, meaning earlier counselling and referral to support services- this can potentially avert the serious societal consequences of chronic medicine misuse (ie- health, economic, social and legal costs) facilitate harmonisation of the supply of S3 medicines across all jurisdictions; and enable provision of information and data, where appropriate, to police and/or law enforcement agencies. From a community pharmacy perspective, the establishment of a POMN system would: provide a powerful, data-driven decision-support tool for pharmacists, electronically linking them, helping them determine if the supply of a medicine is appropriate and generally assisting in applying Quality Use of Medicines principles; broaden the scope of health care intervention provided by pharmacists, to include the monitoring and management of more serious and chronic conditions after diagnosis by an appropriate medical practitioner; facilitate the down-scheduling from the S4 category for medicines requiring initial medical diagnosis but not requiring close medical management; and create a greater level of accountability for pharmacists, consistent with the vision of an expanded primary health care role for the profession, and ensure that a risk-based approach is employed. e) Consumer Benefits The establishment of a POMN system would benefit consumers by: retaining access to effective medicines under the supervision and support of a highly trained health professional, without the need for a prescription; potentially facilitating the down-scheduling of some medicines from the S4 category, because pharmacists would be able to monitor their appropriate use; leading to earlier health professional recognition and assistance for those consumers misusing/abusing medicines assisting to de-stigmatise the purchase of certain medicines by legitimate users, as pharmacists will have a decision support tool which removes any default assumption that they involve misuse/abuse f) Who Performs the Service? g) Collaboration with Other Health Care Professionals Pharmacists Pharmacy assistants The pharmacist is involved in the sale of all S3 medicines to determine the appropriateness of the medicine for the condition being treated, and ensure its safe and proper use. Pharmacy assistants may be trained in order to complete the administrative recording element of the POMN system. Will service delivery require any formal collaboration with other health care professionals? There may be opportunity for the pharmacist to collaborate with health professionals providing the original diagnosis for conditions requiring POMN products. Generally, relevant medicine protocols would also detail referral processes to other health professionals for situations where the pharmacist identifies QUM issues requiring further review or intervention. 3
4 2. Implementation and Enablers a) Stakeholder Consultation Representative bodies from the following areas will need to be consulted in order to fully develop and implement a program: Consumer organisations Funders Government and regulatory bodies - TGA GP organisations Law enforcement agencies Commonwealth and State Pharmacy organisations Pharmacy software vendors Industry Professional insurers b) IT Requirements Is pharmacy software required to deliver this program? Pharmacy software should have a recording and real-time monitoring system that is integrated with existing pharmacy IT to maximise workflow. With the development of e-health records, there is the opportunity for consumers use of S3 medicines to be recorded so details are available to other health professionals as required. c) Infrastructure and Staffing Is a private consultation area required to deliver this program? An appropriate consultation area within the pharmacy will be required to conduct private consultations with patients. Is the program within the pharmacist s/pharmacy assistant s normal scope of practice? Is an additional pharmacist likely to be needed? To be determined - Pharmacies will need to give consideration to the need for another pharmacist to be available to ensure that all professional activities within the pharmacy are adequately managed by a pharmacist. d) Training What additional formal training is likely? No additional training. Apart from introductory instruction for pharmacists and pharmacy assistants in relation to system operation, there should be no special training needs. Does any suitable training exist? To be determined. The availability of training will depend on the format of the system developed. Training for the existing Project STOP system may be able to be reviewed and refined for this purpose. e) Supporting Standards, Procedures and Templates / Checklists Will an amendment to the QCPP requirements be necessary? Strict adherence by pharmacists to professional protocols set out in an auditable standard should ensure the public receives a standardised, quality-assured professional support service. Generic requirements for delivery of health programs and services are set out in Element 3 of the QCPP Standard. As services are developed, the need for supporting templates and procedures can be assessed, and, where not available, the development of new ones should be part of the program structure. Will professional guidelines and/or standards for pharmacists be required? Are there any other national guidelines which need to be taken into account in developing the program to ensure consistency with best practice? 4
5 To be determined. Depending on the interventions included in the service, it will be necessary to confirm if any national guidelines relate to the intervention and, if so, ensure that the service is aligned. f) Legislation/ Regulation Implications There will need to be an amendment to relevant Commonwealth and State/Territory Legislation. POMN should be recognised by the National Pharmacy Board as a professional pharmacy service so it is anticipated that there would be no additional requirements for pharmacist indemnity with insurance companies. 3. Funding Funding Options Possible funding options include: Commonwealth program State/Territory Government User-pays (Would require a review of GST implications ) Has any funding for this program been secured? No. Funding arrangements would also need to be considered for bodies/organisations responsible for monitoring the data; this may be either at Commonwealth or State level. 4. Timelines Timelines Established community pharmacy practice Immediate to short-term implementation (< 30 June 2015) Medium-term implementation(1 July 2015 to 30 June 2020) Longer-term implementation (> 1 July 2020 ) 5
QUM and Continuity of Care A Prescribed Medicines Services and Programs
Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: 1. Program/Service Description QUM and Continuity of Care A Prescribed Medicines Services and Programs a) Background The
More informationNurse Practitioner Frequently Asked Questions
HEALTH SERVICES Nurse Practitioner Frequently Asked Questions The Frequently Asked Questions (FAQs) have been designed to increase awareness and understanding of the Nurse Practitioner role within the
More informationPharmacy Policy (General)
WORKSAFE VICTORIA Pharmacy Policy (General) WorkSafe can pay the reasonable costs of medications and other pharmacy items required as a result of a work-related injury or illness in accordance with Victorian
More informationPolicy for the issue of permits to prescribe Schedule 8 poisons
Policy for the issue of permits to prescribe Schedule 8 poisons May 2011 Introduction The Victorian Drugs, Poisons and Controlled Substances (DPCS) legislation sets out certain circumstances when a medical
More informationStandard 1. Governance for Safety and Quality in Health Service Organisations. Safety and Quality Improvement Guide
Standard 1 Governance for Safety and Quality in Health Service Organisations Safety and Quality Improvement Guide 1 1 1October 1 2012 ISBN: Print: 978-1-921983-27-6 Electronic: 978-1-921983-28-3 Suggested
More informationBetter Outcomes for People Living with Chronic and Complex Health Conditions through Primary Health Care
Submission: Primary Health Care Advisory Group Discussion Paper (August 2015) Better Outcomes for People Living with Chronic and Complex Health Conditions through Primary Health Care August 2015 Contact
More informationClinical Intervention Definitions
Pharmacy Practice Incentive (PPI) Program Clinical Intervention Definitions $97 million over the life of the Agreement (5 years) Clinical Intervention - Definitions A clinical intervention: is a professional
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationAugust 2011. A. Introduction
Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence August 2011 A. Introduction
More informationPart 3 Medical Officer (MO) Work Level Standards
Part 3 Medical Officer (MO) Work Level Standards MEDICAL OFFICER-CLASSES 1 6 GROUP STANDARD The work of positions in this group involves the application of professional medical knowledge and experience
More informationDEPARTMENT OF HEALTH. Targeted Implementation Date 1 st half 2012. Initiative Purpose/Objective Review Period
DEPARTMENT OF HEALTH REVIEWS OF LEGISLATIVE REQUIREMENTS A legislative requirement is an obligation imposed under any legislative instrument which, for the purposes of this initiative, includes primary
More informationSubstance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
More informationProfessional Standards and Guidance for the Sale and Supply of Medicines
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
More informationA Middle Class in the United States? Behind the Counter (BTC) Drugs. Frederick H. Branding, R.Ph., J.D. Rahul Narula
A Middle Class in the United States? Behind the Counter (BTC) Drugs Frederick H. Branding, R.Ph., J.D. Rahul Narula FDA s Regulation of Drugs Federal Food, Drug and Cosmetic Act (FDCA) passed by Congress
More informationGuidelines for dispensing of medicines 6585 08/10
for dispensing of medicines 6585 08/10 for dispensing of medicines Contents Introduction 1 Who needs to use these guidelines? 1 Summary of guidelines 1 1 1 Dispensing precaution safety of prescriptions
More informationSTATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
More informationClinical Governance for Nurse Practitioners in Queensland
Office of the Chief Nursing Officer Clinical Governance for Nurse Practitioners in Queensland A guide Clinical Governance for Nurse Practitioners in Queensland: A guide Queensland Health Office of the
More informationMedication Management Guidelines for Nurses and Midwives
Medication Management Guidelines for Nurses and Midwives 1. Introduction As the statutory body responsible for the regulation of nursing and midwifery practice in Western Australia (WA), the Nurses & Midwives
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationDraft guidance for registered pharmacies providing internet and distance sale, supply or service provision
Draft guidance for registered pharmacies providing internet and distance sale, supply or service provision September 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy
More informationPublic consultation paper
Public consultation paper September 2013 Proposed expanded endorsement for scheduled medicines Draft Registration standard for endorsement of registered nurses and/or registered midwives to supply and
More informationPolicy Paper: Accessible allied health primary care services for all Australians
Policy Paper: Accessible allied health primary care services for all Australians March 2013 Contents Contents... 2 AHPA s call to action... 3 Position Statement... 4 Background... 6 Healthier Australians
More informationAlcohol, Tobacco and Other Drugs Minimum Standard. April 2015
Alcohol, Tobacco and Other Drugs Minimum Standard April 2015 Contents 1 Executive Summary... 2 2 More Information... 2 3 Using this Standard... 2 4 Standard Provisions... 2 4.1 Legislative Requirements...
More informationPatient Group Directions. Guidance and information for nurses
Patient Group Directions Guidance and information for nurses Patient Group Directions Guidance and information for nurses Contents Introduction 4 What is a patient group direction (PGD)? 4 When can PGDs
More informationGuidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles
More information5. 16. Health Law in Canada. Constitutional Division of Power
Health Law in Canada Health care in Canada is a complex subject, some health care services are public, some are private and there are a number of different entities involved in regulating and providing
More informationMEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS
MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory
More informationGuidelines on endorsement as a nurse practitioner
Guidelines on endorsement as a nurse practitioner 7160 Introduction The National Registration and Accreditation Scheme (the National Scheme) for health professionals in Australia commenced on 1 July 2010
More informationLevel 8 - Job description for an advanced nurse practitioner in general practice
Level 8 - Job description for an advanced nurse practitioner in general practice Title: Advanced nurse practitioner in general practice Agenda for Change (AfC) banding: 8 Hours of duty: Responsible to:
More informationSenate Inquiry into Australia s Innovation System
31 July 2014 Senate Standing Committee on Economics PO Box 6100 Parliament House Canberra ACT 2600 By email to: economics.sen@aph.gov.au and uploaded via the Make a submission to an Inquiry page Dear Committee
More informationhealthcare associated infection 1.2
healthcare associated infection A C T I O N G U I D E 1.2 AUSTRALIAN SAFETY AND QUALITY GOALS FOR HEALTH CARE What are the goals? The Australian Safety and Quality Goals for Health Care set out some important
More information4.3 Antidepressant medicines dispensing 18 64 years
4.3 Antidepressant medicines dispensing 18 64 years Context This data item examines the dispensing rates of antidepressant medicines for people aged 18 to 64. These data are sourced from the PBS and relate
More informationSupport to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence
Support to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence SUMMARY 1) Derbyshire Substance misuse service provides Psycho-social treatment interventions for ALL
More informationMichigan Guidelines for the Use of Controlled Substances for the Treatment of Pain
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality
More informationScope of Practice. Background. Approved: 2009 Due for review: 2014
Approved: 2009 Due for review: 2014 Scope of Practice Background Australia s health system is in need of reform in order to meet a range of long-term challenges, including timely access to services, the
More informationJAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.
THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature
More informationGuidelines for Education Requirements for Recognition as Eligible Midwives and Accreditation Standards for programs of study leading to endorsement
Guidelines for Education Requirements for Recognition as Eligible Midwives and Accreditation Standards for programs of study leading to endorsement for scheduled medicines for Eligible Midwives 6447 Contents
More informationNote that the following document is copyright, details of which are provided on the next page.
Please note that the following document was created by the former Australian Council for Safety and Quality in Health Care. The former Council ceased its activities on 31 December 2005 and the Australian
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
More informationQUESTIONS AND ANSWERS HEALTHCARE IDENTIFIERS BILL 2010
About Healthcare Identifiers QUESTIONS AND ANSWERS HEALTHCARE IDENTIFIERS BILL 2010 Q1. What is the Healthcare Identifiers Service? The Healthcare Identifiers (HI) Service will implement and maintain a
More informationJOB DESCRIPTION. Advanced Nurse Practitioner Professional Lead
JOB DESCRIPTION JOB TITLE: RESPONSIBLE TO: LOCATION(S): JOB PROFILE: Advanced Nurse Practitioner Advanced Nurse Practitioner Professional Lead North Bristol Trust Southmead Hospital This role is to work
More informationNATIONAL PARTNERSHIP AGREEMENT ON E-HEALTH
NATIONAL PARTNERSHIP AGREEMENT ON E-HEALTH Council of Australian Governments An agreement between the Commonwealth of Australia and the States and Territories, being: The State of New South Wales The State
More informationDRUG & ALCOHOL POLICY
DRUG & ALCOHOL POLICY Rationale: Koonung Secondary College (KSC) has an interest in the health, personal and legal wellbeing of its students and staff. There is no clear dividing line between the responsibility
More informationUnderstanding Alberta s Drug Schedules
Understanding Alberta s Drug Schedules Preface In May 2002, the provincial drug schedules to the Pharmaceutical Profession Act were amended. In April 2007, the Alberta Regulation 66/2007 to the Pharmacy
More informationGENERAL PRACTICE BASED PHARMACIST
GENERAL PRACTICE BASED PHARMACIST JOB PURPOSE Provide expertise in clinical medicines review 1 and address public health and social needs of patients in GP practices Reduce inappropriate poly-pharmacy
More informationRelease: 1. HLTPH301C Undertake pharmacy technician duties
Release: 1 HLTPH301C Undertake pharmacy technician duties HLTPH301C Undertake pharmacy technician duties Modification History Not Applicable Unit Descriptor Descriptor This unit of competency describes
More informationTHEME: PROMOTING GOOD PRACTICES IN DRUG POLICY DEVELOPMENT AND IMPLEMENTATION
Page 1 AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone 251-11-5517 700 Fax 251-11-5517 844 website: www. africa-union.org 5 th SESSION OF THE AU CONFERENCE OF
More informationRegistration standard: Endorsement as a nurse practitioner
Registration standard: Endorsement as a nurse practitioner Consultation report February 2016 Nursing and Midwifery Board of Australia G.P.O. Box 9958 Melbourne VIC 3001 www.nursingmidwiferyboard.gov.au
More informationAOD Support Services Classification Level: 7.1 Aboriginal Community Organisation Award. 004 Supervisor AOD Support Services
ABORIGINAL ALCOHOL AND DRUG SERVICE POSITION DESCRIPTION SECTION 1: OFFICE IDENTIFICATION EFFECTIVE DATE OF DOCUMENT: SEPTEMBER 2012 Position Description Number: 006 Job Title: AOD Counsellor/Educator
More informationFile No.: 20100701. Guidelines for the Administration of certain substances by aged-care workers in residential aged care services
File No.: 20100701 Guidelines for the Administration of certain substances by aged-care workers in residential aged care services 1 September 2010 Contents 1. Introduction...4 2. Regulation 95EA...5 3.
More informationAPHA Response to the Draft Report (Sept 2014) The Competition Policy Review - 2014. Australian Private Hospitals Association ABN 82 008 623 809
APHA Response to the Draft Report (Sept 2014) The Competition Policy Review - 2014 Australian Private Hospitals Association ABN 82 008 623 809 Executive Summary The Australian Private Hospitals Association
More informationRACGP General Practice Patient Charter Australian Primary Health Care Nurses Association (APNA) September 2014
RACGP General Practice Patient Charter Australian Primary Health Care Nurses Association (APNA) September 2014 For further information and comment please contact Kathy Bell, Chief Executive Officer, Australian
More informationMichigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain
JENNIFER M. GRANHOLM GOVERNOR STATE OF MICHIGAN DEPARTMENT OF COMMUNITY HEALTH LANSING JANET OLSZEWSKI DIRECTOR Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment
More informationBOARD NOTICE 271 OF 2013 THE SOUTH AFRICAN PHARMACY COUNCIL RULES RELATING TO GOOD PHARMACY PRACTICE
STAATSKOERANT, 20 DESEMBER 2013 No. 37193 3 BOARD NOTICES BOARD NOTICE 271 OF 2013 THE SOUTH AFRICAN PHARMACY COUNCIL RULES RELATING TO GOOD PHARMACY PRACTICE The South African Pharmacy Council herewith
More informationEPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices
EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical 03/09/2013 In Vitro Diagnostic medical devices include all tests performed to provide a diagnosis by assessing
More informationNurse Practitioners in NSW
Policy Directive Document Number PD2012_026 Publication date 15-May-2012 Nurse Practitioners in NSW Ministry of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059
More informationNational uniform legislation Acts of jurisdictions implementing uniform legislation [updated March 2015]
National uniform legislation Acts of jurisdictions implementing uniform legislation [updated March 2015] Subject /applied Cth Act (if applicable) State/Territory Act (if applicable) AGVET National Agricultural
More informationHealth Care Job Information Sheet #10. Pharmacy
Health Care Job Information Sheet #10 Pharmacy A. Occupations A. Occupations 1) Pharmacist 2) Pharmacy Technician/ Assistant B. Labour Market Prospects C. ITPs in the Field D. Links 1) Pharmacist Regulated
More informationService Provision and Service Descriptions (standards) for Approved Workplace Rehabilitation Providers
Service Provision and (standards) for Approved Providers Service Provision and (standards) for Approved Workplace Rehabilitation Providers Service delivery requirements for Providers relating to the principles
More informationHIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM. Western Australia Administrative Guidelines
HIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM Western Australia Administrative Guidelines Pharmaceutical Services Branch Health Protection Group Table of Contents BACKGROUND...1 Overview...1 AHMAC
More informationColorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
More informationHarness Care Cooperative Ltd Quality primary care services provided through local cooperation Company registration: 06584450
Harness Care Cooperative Ltd Quality primary care services provided through local cooperation Company registration: 06584450 Job Description Job title: Nurse Practitioner /Lead Nurse ACCOUNTIBILITY The
More informationStandard 5. Patient Identification and Procedure Matching. Safety and Quality Improvement Guide
Standard 5 Patient Identification and Procedure Matching Safety and Quality Improvement Guide 5 5 5October 5 2012 ISBN: Print: 978-1-921983-35-1 Electronic: 978-1-921983-36-8 Suggested citation: Australian
More informationPRINCIPLES FOR ACCESSING AND USING PUBLICLY-FUNDED DATA FOR HEALTH RESEARCH
TARGETED CONSULTATION DRAFT National Health and Medical Research Council PRINCIPLES FOR ACCESSING AND USING PUBLICLY-FUNDED DATA FOR HEALTH RESEARCH Developed by NHMRC s Prevention and Community Health
More information02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
More informationGuidance for Industry
Guidance for Industry Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With Approved Applications Small Entity Compliance Guide U.S. Department of
More informationClinical Governance for Nurse Practitioners in Queensland
Office of the Chief Nursing Officer Clinical Governance for Nurse Practitioners in Queensland A guide Clinical Governance for Nurse Practitioners in Queensland: A guide Queensland Health Office of the
More informationBarton Deakin: Commission of Audit Report Health. 7 May 2014
Barton Deakin: Commission of Audit Report Health 7 May 2014 The Report delivered to the Government by the National Commission of Audit contained several recommendations to reform the Australian health
More informationCRITERIA AND OPERATIONAL STANDARDS FOR WORKPLACE REHABILITATION PROVIDERS 2015
Safety, Rehabilitation and Compensation Act 1988 Sections 34D and 34E CRITERIA AND OPERATIONAL STANDARDS FOR WORKPLACE REHABILITATION PROVIDERS 2015 Pursuant to sections 34D and 34E of the Safety, Rehabilitation
More informationPharmacist independent prescribing programme learning outcomes and indicative content
Pharmacist independent prescribing programme learning outcomes and indicative content Learning outcomes All providers of GPhC accredited independent prescribing programmes need to ensure that following
More informationInhaler Technique Check
Protocol October 2015 Version 1.3 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 3 Staff Roles... 3 Facilities to support the program...
More informationOPERATIONAL GUIDELINES FOR THE ACCESS TO ALLIED PSYCHOLOGICAL SERVICES INITIATIVE (ATAPS) SUICIDE PREVENTION SERVICE
OPERATIONAL GUIDELINES FOR THE ACCESS TO ALLIED PSYCHOLOGICAL SERVICES INITIATIVE (ATAPS) SUICIDE PREVENTION SERVICE JANUARY 2012 Mental Health Services Branch Mental Health and Drug Treatment Division
More informationTAFE SA Student Alcohol and Other Drug Policy Under the umbrella of Drugs and Alcohol Policy (DFEEST OHS&IM 026)
TAFE SA Student Alcohol and Other Drug Policy Under the umbrella of Drugs and Alcohol Policy (DFEEST OHS&IM 026) 1. Purpose of the policy The purpose of the Student Alcohol and Other Drug Policy is to
More informationJob Description Nurse Practitioner
Job Description Nurse Practitioner The post holder is responsible for the delivery of general practice nursing to the whole practice population and specialised care to patients with HIV, their carers,
More informationJohn Keel, CPA State Auditor. An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy. August 2015 Report No.
John Keel, CPA State Auditor An Audit Report on Inspections of Compounding Pharmacies at the Board of Pharmacy Report No. 15-039 An Audit Report on Inspections of Compounding Pharmacies at the Board of
More informationCommunity Pharmacy in 2016/17 and beyond - proposals Stakeholder briefing sessions
Community Pharmacy in 2016/17 and beyond - proposals Stakeholder briefing sessions 1 CONTENTS Contents This presentation describes our vision for community pharmacy, and outlines proposals for achieving
More informationCOCIR contribution to the public consultation on Personal Data Protection in the EU 1
COCIR contribution to the public consultation on Personal Data Protection in the EU 1 European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry Bd. A. Reyers 80, 1030
More informationConsultation Report. Consultation Report: Personal Injuries (Liabilities and Damages) Act - Assessments of Permanent Impairment JUNE 2015
DEPARTMENT OF THE ATTORNEY-GENERAL AND JUSTICE Consultation Report Consultation Report: Personal Injuries (Liabilities and Damages) Act - Assessments of Permanent Impairment JUNE 2015 Legal Policy 68 The
More informationPOSITION DESCRIPTION Nurse Practitioner (AGED CARE)
POSITION DESCRIPTION Nurse Practitioner (AGED CARE) THE ORGANISATION Rural Northwest Health is a public health service funded by State and Commonwealth Government and supported by the local community.
More informationGUIDELINES ON COMPOUNDING OF MEDICINES. March 2015. PharmBA1502 01
GUIDELINES ON COMPOUNDING OF MEDICINES March 2015 PharmBA1502 01 Contents Who needs to use these guidelines?............................................. 3 Introduction..........................................................
More informationPrivate Health Insurance: Proposal for Quality Assurance Requirements for Privately Insured Services
Private Health Insurance: Proposal for Quality Assurance Requirements for Privately Insured Services As you may be aware, the Department of Health and Aging, Private Health Insurance Branch as part of
More informationManaging Medicines Access Programs. Guiding principles for the governance of Medicines Access Programs in Australian hospitals
Managing Medicines Access Programs Guiding principles for the governance of Medicines Access Programs in Australian hospitals May 2015 Council of Australian Therapeutic Advisory Groups Address: c/ - NSW
More informationIntroduction Continuing Competence Framework Components Glossary of Terms. ANMC Continuing Competence Framework
continuing competence framework february 2009 Introduction Continuing Competence Framework Components Glossary of Terms ANMC Continuing Competence Framework Component Requirement PROFESSIONAL PORTFOLIO
More informationFuture Service Directions
Alcohol, Tobacco and Other Drug Services Tasmania Future Service Directions A five year plan 2008/09 2012/13 Department of Health and Human Services Contents Foreword... 5 Introduction... 6 Australian
More informationThe Australian Supply Chain Reform Past, Present and Future
The Australian Supply Chain Reform Past, Present and Future Kate Ebrill Head of National Service Operation and Management GS1 Healthcare Conference Copenhagen, Denmark 22 October 2014 1 National E-Health
More informationLegislative and Governance Forum on Food Regulation (convening as the Australia and New Zealand Food Regulation Ministerial Council)
Legislative and Governance Forum on Food Regulation (convening as the Australia and New Zealand Food Regulation Ministerial Council) Policy Guideline on Food Safety Management for General Food Service
More informationBriefing for APHA Members - The National Commission of Audit Report, May 2014.
Briefing for APHA Members - The National Commission of Audit Report, May 2014. The Commission of Audit s final report was released at 2pm on Thursday 1 May 2013. The National Commission of Audit was announced
More informationAIS Sports Science/Sports Medicine Best Practice Principles
AIS Sports Science/Sports Medicine Best Practice Principles Introduction For the Australian Sports Commission (ASC) and Australian Institute of Sport (AIS), integrity in sport is paramount. Accordingly,
More informationNew Frontiers Old Cowboys: A Consumer Perspective on ehealth Initiatives
New Frontiers Old Cowboys: A Consumer Perspective on ehealth Initiatives Nicola Ballenden The move to an efficient, patient-focused health system as outlined by John Dwyer and the Australian Health Reform
More informationAustralian Safety and Quality Framework for Health Care
Activities for the HEALTHCARE TEAM Australian Safety and Quality Framework for Health Care Putting the Framework into action: Getting started Contents Principle: Consumer centred Areas for action: 1.2
More informationPRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE
PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE MARCH 2013 MONOGRAPHS IN PROSTATE CANCER OUR VISION, MISSION AND VALUES Prostate Cancer Foundation of Australia (PCFA)
More informationMTAA KEY POLICIES FOR 2013 ELECTION. 1 February 2013. 1. Improving reimbursement of medical technologies by private health insurance
MTAA KEY POLICIES FOR 2013 ELECTION 1 February 2013 1. Improving reimbursement of medical technologies by private health insurance Medical technology is not funded by the Commonwealth Government in the
More informationCMS-CMMI Releases Enhanced Medication Therapy Management (MTM) Model Test Beginning in January 2017
October 5, 2015 www.amcp.org CMS-CMMI Releases Enhanced Medication Therapy Management (MTM) Model Test Beginning in January 2017 Pursuant to a memorandum issued on September 28, 2015, the Centers for Medicare
More informationPOLICY STATEMENT 5.17
POLICY STATEMENT 5.17 DENTAL RECORDS 1 (Including ADA Guidelines for Dental Records) 1. Introduction 1.1 Dentists have a professional and a legal obligation to maintain clinically relevant, accurate and
More informationSelf Care in New Zealand
Self Care in New Zealand A roadmap toward greater personal responsibility in managing health Prepared by the New Zealand Self Medication Industry Association. July 2009 What is Self Care? Self Care describes
More informationAccess to Community Pharmacy Services in Rural/ Remote Australia
Access to Community Pharmacy Services in Rural/ Remote Australia Position The Pharmacy Guild of Australia believes that the standard of health care for rural/remote areas should be equal to the standards
More informationAMA CDT STRATEGIC PLAN 2014-16
This Strategic Plan is designed to guide the activities of the Council over an approximately three-year cycle, vertically integrating with organisation-wide Strategic Plans and planning processes, where
More informationMAKING BEST USE OF THE PHARMACY WORKFORCE A CONSULTATION PAPER
MAKING BEST USE OF THE PHARMACY WORKFORCE A CONSULTATION PAPER 1. CHAPTER 1: SUPPORTING CHANGE THROUGH BETTER USE OF SKILL MIX The Need for Change 1. Pharmacists have extensive training in the actions,
More informationGUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES
GUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES January 2009 Contents Page Number 1.0 Introduction 3 2.0 Background 4 3.0 Criteria 5 3.1 Referral 5 3.2 Levels of assistance/consent
More information